337 related articles for article (PubMed ID: 15282651)
1. Prevalence of anti-PF4/heparin antibodies and the HIT syndrome in cardiovascular medicine.
Mattioli AV
Semin Thromb Hemost; 2004 Jun; 30(3):291-5. PubMed ID: 15282651
[TBL] [Abstract][Full Text] [Related]
2. Heparin-induced thrombocytopenia.
Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
[TBL] [Abstract][Full Text] [Related]
3. Heparin-induced thrombocytopenia: a stoichiometry-based model to explain the differing immunogenicities of unfractionated heparin, low-molecular-weight heparin, and fondaparinux in different clinical settings.
Greinacher A; Alban S; Omer-Adam MA; Weitschies W; Warkentin TE
Thromb Res; 2008; 122(2):211-20. PubMed ID: 18262226
[TBL] [Abstract][Full Text] [Related]
4. Close approximation of two platelet factor 4 tetramers by charge neutralization forms the antigens recognized by HIT antibodies.
Greinacher A; Gopinadhan M; Günther JU; Omer-Adam MA; Strobel U; Warkentin TE; Papastavrou G; Weitschies W; Helm CA
Arterioscler Thromb Vasc Biol; 2006 Oct; 26(10):2386-93. PubMed ID: 16873726
[TBL] [Abstract][Full Text] [Related]
5. Decreased prevalence of heparin-induced thrombocytopenia with low-molecular-weight heparin and related drugs.
Walenga JM; Jeske WP; Prechel MM; Bacher P; Bakhos M
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():69-80. PubMed ID: 15085468
[TBL] [Abstract][Full Text] [Related]
6. Heparin-induced thrombocytopenia: an autoimmune disorder regulated through dynamic autoantigen assembly/disassembly.
Cines DB; Rauova L; Arepally G; Reilly MP; McKenzie SE; Sachais BS; Poncz M
J Clin Apher; 2007 Feb; 22(1):31-6. PubMed ID: 17285619
[TBL] [Abstract][Full Text] [Related]
7. Heparin-induced thrombocytopenia: IgG binding to PF4-heparin complexes in the fluid phase and cross-reactivity with low molecular weight heparin and heparinoid.
Newman PM; Swanson RL; Chong BH
Thromb Haemost; 1998 Aug; 80(2):292-7. PubMed ID: 9716155
[TBL] [Abstract][Full Text] [Related]
8. Heparin-induced thrombocytopenia: diagnosis and management.
Liebman HA
Vascular; 2008; 16 Suppl 1():S71-6. PubMed ID: 18544310
[TBL] [Abstract][Full Text] [Related]
9. Delayed-onset HIT caused by low-molecular-weight heparin manifesting during fondaparinux prophylaxis.
Alsaleh KA; Al-Nasser SM; Bates SM; Patel A; Warkentin TE; Arnold DM
Am J Hematol; 2008 Nov; 83(11):876-8. PubMed ID: 18803278
[TBL] [Abstract][Full Text] [Related]
10. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
11. Testing for heparin-induced thrombocytopenia antibodies.
Warkentin TE; Sheppard JA
Transfus Med Rev; 2006 Oct; 20(4):259-72. PubMed ID: 17008164
[TBL] [Abstract][Full Text] [Related]
12. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
[TBL] [Abstract][Full Text] [Related]
13. Heparin-induced thrombocytopenia: diagnosis and management.
Hassell K
Thromb Res; 2008; 123 Suppl 1():S16-21. PubMed ID: 18829068
[TBL] [Abstract][Full Text] [Related]
14. When heparin causes thrombosis: significance, recognition, and management of heparin-induced thrombocytopenia in dialysis patients.
Chang JJ; Parikh CR
Semin Dial; 2006; 19(4):297-304. PubMed ID: 16893407
[TBL] [Abstract][Full Text] [Related]
15. Newer insights on the mechanism of heparin-induced thrombocytopenia.
Walenga JM; Jeske WP; Prechel MM; Bakhos M
Semin Thromb Hemost; 2004 Feb; 30 Suppl 1():57-67. PubMed ID: 15085467
[TBL] [Abstract][Full Text] [Related]
16. HITlights: a career perspective on heparin-induced thrombocytopenia.
Warkentin TE
Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
[TBL] [Abstract][Full Text] [Related]
17. An update on the prevalence and characterization of H-PF4 antibodies in Asian-Indian patients.
Kannan M; Saxena R; Adiguzel C; Fareed J
Semin Thromb Hemost; 2009 Apr; 35(3):337-43. PubMed ID: 19452409
[TBL] [Abstract][Full Text] [Related]
18. A critical evaluation of assays for detecting antibodies to the heparin-PF4 complex.
Francis JL
Semin Thromb Hemost; 2004 Jun; 30(3):359-68. PubMed ID: 15282659
[TBL] [Abstract][Full Text] [Related]
19. [Platelet factor 4, target of anti-heparin antibodies: application to biological diagnosis of heparin-induced thrombopenia].
Amiral J
Ann Med Interne (Paris); 1997; 148(2):142-9. PubMed ID: 9238439
[TBL] [Abstract][Full Text] [Related]
20. Detection and significance of heparin-platelet factor 4 antibodies.
Francis JL
Semin Hematol; 2005 Jul; 42(3 Suppl 3):S9-14. PubMed ID: 16105558
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
